Search research articles
Contact Us
Filters
Showing results (21-30 of 116) with videos related to
Page
of 12
Sort By:
Klinische Monatsblatter Fur Augenheilkunde
|
April 23, 2024
The Importance of QuantiFERON Gold Plus Test for the Diagnosis of Presumed Ocular Tuberculosis
Francesca Bruzzone, Margherita Plebani, Aikaterini Koryllou, et al.
Vaccine
|
September 6, 2018
Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial
Matteo Mombelli, Nils Rettby, Matthieu Perreau, et al.
Arthritis Research & Therapy
|
June 1, 2023
Real-life drug retention rate and safety of rituximab when treating rheumatic diseases: a single-centre Swiss retrospective cohort study
Alexandre Dumusc, Fahad Alromaih, Matthieu Perreau, et al.
Current Opinion in HIV and AIDS
|
February 9, 2021
Chimeric antigen receptor T-cell therapy for HIV cure
Oscar Alfageme-Abello, Raphaël Porret, Matthieu Perreau, et al.
SSM - Population Health
|
April 3, 2025
Why gender and sex matter in infectious disease modelling: A conceptual framework
Diane Auderset, Julien Riou, Carole Clair, et al.
Blood
|
September 20, 2002
gp120-mediated induction of the MAPK cascade is dependent on the activation state of CD4(+) lymphocytes
Sandrina Kinet, Fréderic Bernard, Cédric Mongellaz, et al.
Journal of Virology
|
February 5, 2010
Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R{alpha} (CD127) and perforin expression
Cristina Cellerai, Matthieu Perreau, Virginie Rozot, et al.
European Journal of Immunology
|
December 7, 2011
Modulation of human memory T-cell function by different antigen-presenting cells
Matthieu Perreau, Hugh C Welles, Alexandre Harari, et al.
Clinical & Developmental Immunology
|
December 11, 2012
Functional avidity: a measure to predict the efficacy of effector T cells?
Selena Viganò, Daniel T Utzschneider, Matthieu Perreau, et al.
Frontiers in Immunology
|
July 28, 2018
IRF5 Is a Key Regulator of Macrophage Response to Lipopolysaccharide in Newborns
Anina Schneider, Manuela Weier, Jacobus Herderschee, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 116) with videos related to
Sort By:
Page
of 12
Klinische Monatsblatter Fur Augenheilkunde
|
April 23, 2024
The Importance of QuantiFERON Gold Plus Test for the Diagnosis of Presumed Ocular Tuberculosis
Francesca Bruzzone, Margherita Plebani, Aikaterini Koryllou, et al.
Vaccine
|
September 6, 2018
Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial
Matteo Mombelli, Nils Rettby, Matthieu Perreau, et al.
Arthritis Research & Therapy
|
June 1, 2023
Real-life drug retention rate and safety of rituximab when treating rheumatic diseases: a single-centre Swiss retrospective cohort study
Alexandre Dumusc, Fahad Alromaih, Matthieu Perreau, et al.
Current Opinion in HIV and AIDS
|
February 9, 2021
Chimeric antigen receptor T-cell therapy for HIV cure
Oscar Alfageme-Abello, Raphaël Porret, Matthieu Perreau, et al.
SSM - Population Health
|
April 3, 2025
Why gender and sex matter in infectious disease modelling: A conceptual framework
Diane Auderset, Julien Riou, Carole Clair, et al.
Blood
|
September 20, 2002
gp120-mediated induction of the MAPK cascade is dependent on the activation state of CD4(+) lymphocytes
Sandrina Kinet, Fréderic Bernard, Cédric Mongellaz, et al.
Journal of Virology
|
February 5, 2010
Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R{alpha} (CD127) and perforin expression
Cristina Cellerai, Matthieu Perreau, Virginie Rozot, et al.
European Journal of Immunology
|
December 7, 2011
Modulation of human memory T-cell function by different antigen-presenting cells
Matthieu Perreau, Hugh C Welles, Alexandre Harari, et al.
Clinical & Developmental Immunology
|
December 11, 2012
Functional avidity: a measure to predict the efficacy of effector T cells?
Selena Viganò, Daniel T Utzschneider, Matthieu Perreau, et al.
Frontiers in Immunology
|
July 28, 2018
IRF5 Is a Key Regulator of Macrophage Response to Lipopolysaccharide in Newborns
Anina Schneider, Manuela Weier, Jacobus Herderschee, et al.
Page
of 12